Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV

Human cytomegalovirus (HCMV) infects more than 70% of the human population worldwide. HCMV is responsible for high morbidity and mortality in immunocompromised patients and remains the leading viral cause of congenital birth defects. Despite considerable efforts in vaccine and therapeutic developmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Perotti, Michela, Perez, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019358/
https://www.ncbi.nlm.nih.gov/pubmed/31905677
http://dx.doi.org/10.3390/v12010035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019358/
https://www.ncbi.nlm.nih.gov/pubmed/31905677
http://dx.doi.org/10.3390/v12010035

Ejemplares similares